US Stock MarketDetailed Quotes

TBPH Theravance Biopharma

Watchlist
  • 8.210
  • +0.150+1.86%
Close Oct 1 16:00 ET
  • 8.210
  • 0.0000.00%
Post 16:22 ET
401.65MMarket Cap-8642P/E (TTM)

Theravance Biopharma Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Theravance Biopharma Q2 2024 Earnings Date

Currency：USDAug 5, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
15.31M
14.26M
-1.05M
Miss Est.
+11.33%
+3.69%
-6.87%
EPS
-0.21
-0.34
-0.13
Miss Est.
+25.90%
-21.43%
-63.93%
Analyst Rating
Buy

Oct 1, 2024

Theravance Biopharma Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 5 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 26.286M--
--2024/Q3-- / 15.424M--
Aug 5, 20242024/Q214.256M / 15.307M--
May 13, 20242024/Q114.503M / 13.950M--
Feb 26, 20242023/Q417.565M / 17.575M--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 26.286M--
--2024/Q3-- / 15.424M--
Aug 5, 20242024/Q214.256M / 15.307M--
May 13, 20242024/Q114.503M / 13.950M--
Feb 26, 20242023/Q417.565M / 17.575M--

Unlock Free Earnings Estimates

Theravance Biopharma Earnings Reports

  • Theravance Biopharma | 10-Q: Q2 2024 Earnings Report

    Aug 8 17:00 ET

  • Theravance Biopharma | 10-Q: Q1 2024 Earnings Report

    May 15 06:40 ET

  • Theravance Biopharma | 10-K: FY2023 Annual Report

    Mar 1 16:37 ET

  • Theravance Biopharma | 10-Q: Q3 2023 Earnings Report

    Nov 9, 2023 16:46 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Oct 1, 2024

    Buy

    • Buy

      33.33%

    • Hold

      66.67%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg

    No Data